Last reviewed · How we verify

NCT04014127: CRIB-FLOW

Coronary Microvascular Dysfunction in Chronic Kidney Disease

Status unknown Last updated 10 July 2019
What this trial tests

trial testing Coronary flow reserve assessment in Kidney Disease, Chronic in 100 participants. Status unknown.

Timeline
7 May 2019
Primary endpoint
31 August 2020
31 December 2020

Quick facts

Lead sponsorUniversity Hospital Birmingham NHS Foundation Trust
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date7 May 2019
Primary completion31 August 2020
Estimated completion31 December 2020
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital Birmingham NHS Foundation Trust

Who can join

18 and older, any sex, with Kidney Disease, Chronic or Myocardial Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an observational study assessing coronary microvascular function in healthy controls with normal kidney function, living kidney donors, pre-dialysis patients with chronic kidney disease stage 5 and patients on peritoneal dialysis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Coronary flow velocity reserve and inflammatory markers in living kidney donors.
    Radhakrishnan A, Price AM, Pickup LC, Law JP, et al · · 2020 · cited 7× · PMID 32805328 · DOI 10.1016/j.ijcard.2020.08.013

Verify or expand the search:

Other recruiting trials for Kidney Disease, Chronic

Currently open trials in the same condition.

Other University Hospital Birmingham NHS Foundation Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04014127.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing